Factors Contributing to Exacerbating Vulnerabilities in Global Clinical Trials

Background: Although policies and guidelines make use of the concept of vulnerability, few define it. The European Union's directive for clinical trials does not include explanations for or the reasoning behind the designation of certain groups as vulnerable. Emerging economies from lower middl...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Ricardo E., Amato, Angélica A., Guilhem, Dirce B., de Carvalho, Marta R., Lima, Elisangela da C., Novaes, Maria Rita C. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776907/
https://www.ncbi.nlm.nih.gov/pubmed/29403381
http://dx.doi.org/10.3389/fphar.2017.00999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5776907/
https://www.ncbi.nlm.nih.gov/pubmed/29403381
http://dx.doi.org/10.3389/fphar.2017.00999

Ejemplares similares